A Randomized Controlled Comparison of Azithromycin and Ofloxacin for Treatment of Multidrug-Resistant or Nalidixic Acid-Resistant Enteric Fever

To examine the efficacy and safety of short courses of azithromycin and ofloxacin for treating multidrug-resistant (MDR, i.e., resistant to chloramphenicol, ampicillin, and cotrimoxazole) and nalidixic acid-resistant enteric fever, azithromycin (1 g once daily for 5 days at 20 mg/kg/day) and ofloxac...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Chinh, Nguyen Tran, Parry, Christopher M., Ly, Nguyen Thi, Ha, Huynh Duy, Thong, Mai Xuan, Diep, To Song, Wain, John, White, Nicholas J., Farrar, Jeremy J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Clinical Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89974/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10858343/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.7.1855-1859.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!